A Phase 2 Study of Pemetrexed Versus Pemetrexed Plus Erlotinib in Second-Line Treatment in Patients With Nonsquamous NSCLC.
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2014
At a glance
- Drugs Erlotinib; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Sep 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 12 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History